16-Jun-2021
Change of Director's Interest Notice Change of Director's Interest Notice

15-Jun-2021
Investor presentation, 15 June 2021 Investor presentation, 15 June 2021

15-Jun-2021
Initial Director's Interest Notice Initial Director's Interest Notice

15-Jun-2021
Neuren CEO Jon Pilcher appointed to board of directors Neuren CEO Jon Pilcher appointed to board of directors

10-Jun-2021
Neuren to present at MST Access investor conference Neuren to present at MST Access investor conference

10-Jun-2021
Update - Annual General Meeting 2021 Update - Annual General Meeting 2021

1-Jun-2021
Positive FDA meetings enable INDs for three Phase 2 trials Positive FDA meetings enable INDs for three Phase 2 trials

21-May-2021
Virtual AGM online guide Virtual AGM online guide

21-May-2021
Notice of Annual General Meeting/Proxy Form Notice of Annual General Meeting/Proxy Form

29-Apr-2021
New patent issued to 2032 for Neuren's trofinetide in Canada New patent issued to 2032 for Neuren's trofinetide in Canada